230 related articles for article (PubMed ID: 21824752)
1. Interaction of mephedrone with dopamine and serotonin targets in rats.
Martínez-Clemente J; Escubedo E; Pubill D; Camarasa J
Eur Neuropsychopharmacol; 2012 Mar; 22(3):231-6. PubMed ID: 21824752
[TBL] [Abstract][Full Text] [Related]
2. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
López-Arnau R; Martínez-Clemente J; Pubill D; Escubedo E; Camarasa J
Br J Pharmacol; 2012 Sep; 167(2):407-20. PubMed ID: 22509960
[TBL] [Abstract][Full Text] [Related]
3. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
[TBL] [Abstract][Full Text] [Related]
4. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.
Suyama JA; Sakloth F; Kolanos R; Glennon RA; Lazenka MF; Negus SS; Banks ML
J Pharmacol Exp Ther; 2016 Jan; 356(1):182-90. PubMed ID: 26645638
[TBL] [Abstract][Full Text] [Related]
5. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
6. A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake.
Dallanoce C; Canovi M; Matera C; Mennini T; De Amici M; Gobbi M; De Micheli C
Bioorg Med Chem; 2012 Nov; 20(21):6344-55. PubMed ID: 23022052
[TBL] [Abstract][Full Text] [Related]
7. Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone.
López-Arnau R; Martínez-Clemente J; Rodrigo T; Pubill D; Camarasa J; Escubedo E
Toxicol Appl Pharmacol; 2015 Jul; 286(1):27-35. PubMed ID: 25817894
[TBL] [Abstract][Full Text] [Related]
8. Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone.
den Hollander B; Rozov S; Linden AM; Uusi-Oukari M; Ojanperä I; Korpi ER
Pharmacol Biochem Behav; 2013 Jan; 103(3):501-9. PubMed ID: 23099177
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of McN-5707 as a potential antidepressant.
Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
[TBL] [Abstract][Full Text] [Related]
10. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
Berzétei IP; Bagdy E; Hardy M; Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077
[TBL] [Abstract][Full Text] [Related]
11. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
[TBL] [Abstract][Full Text] [Related]
12. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
Wells GB; Lopez MC; Tanaka JC
Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
[TBL] [Abstract][Full Text] [Related]
13. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.
Hadlock GC; Webb KM; McFadden LM; Chu PW; Ellis JD; Allen SC; Andrenyak DM; Vieira-Brock PL; German CL; Conrad KM; Hoonakker AJ; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2011 Nov; 339(2):530-6. PubMed ID: 21810934
[TBL] [Abstract][Full Text] [Related]
14. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.
Ng NK; Lee HS; Wong PT
J Neurosci Res; 1999 Mar; 55(5):600-7. PubMed ID: 10082082
[TBL] [Abstract][Full Text] [Related]
15. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
16. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
[TBL] [Abstract][Full Text] [Related]
17. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex.
Gobbi M; Valle FD; Ciapparelli C; Diomede L; Morazzoni P; Verotta L; Caccia S; Cervo L; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):262-9. PubMed ID: 10543427
[TBL] [Abstract][Full Text] [Related]
18. Rapid and reversible effects of methamphetamine on dopamine transporters.
Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
Masserano JM; Venable D; Wyatt RJ
J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
[TBL] [Abstract][Full Text] [Related]
20. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
Borawska M; Wiśniewski K
Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
